Acquisition of EUROIMMUN by PerkinElmer

PerkinElmer, Inc., the global leader in innovation for a "healthier world," officially announced on December 19, 2017 that the acquisition of EUROIMMUN Medical Laboratory Diagnostics AG, announced in June 2017, was properly completed.

"I am pleased to have entrusted EUROIMMUN to PerkinElmer, a company I believe we share our important mission and ensure the continuity of our culture and innovation that we have developed over the last thirty years." said Professor Winfried Stöcker, founder and CEO of EUROIMMUN.

In the connection with the above change, we would like to inform our customers and business partners that this change has no impact on the operation of DYNEX and at the same time does not affect the fulfillment of existing or future obligations regarding the operation of DYNEX on the Czech and Slovak market.